Levetiracetam accumulation in renal failure causing myoclonic encephalopathy with triphasic waves

Seizure

Volumn 18, Issue 5, 2009, Pages 376-378

  Vulliemoz, Serge ^a   Iwanowski, Patricia ^b   Landis, Theodor ^b   Jallon, Pierre ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Intoxication; Levetiracetam; Myoclonus; Renal failure; Triphasic waves

Indexed keywords

ETIRACETAM; VALPROIC ACID;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; KIDNEY FUNCTION; MYOCLONUS; PRIORITY JOURNAL; RELAPSE; TONIC CLONIC SEIZURE;

AGED, 80 AND OVER; ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; KIDNEY FAILURE; PIRACETAM;

EID: 67349129800     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2009.01.006     Document Type: Article

References (14)

1. Bickford R.G., and Butt H.R. Hepatic coma: the electroencephalograph pattern. J Clin Invest 34 (1955) 790-799
2. Blume W.T. Drug effects on EEG. J Clin Neurophysiol 23 4 (2006) 306-311
3. Jallon P., Fankhauser L., Du Pasquier R., Coeytaux A., Picard F., Hefft S., et al. Severe but reversible encephalopathy associated with cefepime. Neurophysiol Clin 30 6 (2000) 383-386
4. Karnaze D.S., and Bickford R.G. Triphasic waves: a reassessment of their significance. Electroencephalogr Clin Neurophysiol 57 3 (1984) 193-198
5. Schauble B., Castillo P.R., Boeve B.F., and Westmoreland B.F. EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol 114 1 (2003) 32-37
6. Specchio L.M., Gambardella A., Giallonardo A.T., Michelucci R., Specchio N., Boero G., et al. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy. Epilepsy Res 71 1 (2006) 32-39
7. Genton P., and Gelisse P. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology 57 6 (2001) 1144-1145
8. Wnuk W. Simultaneous determination of seventeen antiepileptic compounds in serum by isocratic reversed-phase liquid chromatography. Ther Drug Monit 23 (2001) 478
9. Johannessen S.I., Battino D., Berry D.J., Bialer M., Kramer J., Tomson T., et al. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 25 3 (2003) 347-363
10. Neufeld M.Y. Periodic triphasic waves in levodopa-induced encephalopathy. Neurology 42 2 (1992) 444-446
11. Patsalos P.N., Ghattaura S., Ratnaraj N., and Sander J.W. In situ metabolism of levetiracetam in blood of patients with epilepsy. Epilepsia 47 11 (2006) 1818-1821
12. Keswani S.C., Kossof E.H., Kreis G.L., and Hagerty C. Amelioration of spinal myoclonus with levetiracetam. J Neurol Neurosurg Psychiatry 73 4 (2002) 457-458
13. Mancuso M., Galli R., Pizzanelli C., Filosto M., Siciliano G., and Murri L. Antimyoclonic effect of levetiracetam in MERRF syndrome. J Neurol Sci 243 1-2 (2006) 97-99
14. Striano P., Manganelli F., Bocella P., Peretti A., and Striano S. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. Mov Disord 20 12 (2005) 1610-1614